Your support fuels our research to #EndALS! Donate Now


TDI 210

Scientists at the ALS Therapy Development Institute are conducting research on this small molecule to determine whether or not it can be used as an effective treatment for ALS by addressing the dysfunctional UPR in motor neurons of PALS.


Type: Small Molecule
Stage: Preclinical
Status: Active
Sponsor: ALS Therapy Development Institute

TDI Says:

We are working to develop a formulation strategy for this small molecule so that it can be effectively screened using preclinical models of ALS.

Comment on this Topic

(All comments are moderated before they appear here.)